Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Agata Olejniczak"'
Autor:
Magdalena Szaryńska, Agata Olejniczak-Kęder, Adrian Zubrzycki, Anna Wardowska, Zbigniew Kmieć
Publikováno v:
Applied Sciences, Vol 11, Iss 21, p 10009 (2021)
Cancer cells, especially cancer stem cells (CSCs), are known for their therapeutic resistance and ability to induce a cancer relapse even many years after successful treatment. The quest for a novel protocol utilizing some commonly used non-oncologic
Externí odkaz:
https://doaj.org/article/f238bb1d04a6494ca9f44fcad3067636
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 11; Pages: 9644
Colorectal cancer (CRC) is one of the most lethal malignancies worldwide, so the attempts to find novel therapeutic approaches are necessary. The aim of our study was to analyze how chemical modifications influence physical, chemical, and biological
Autor:
Olga Rostkowska, Agata Olejniczak‑Kęder, Piotr Spychalski, Magdalena Szaryńska, Jarek Kobiela
Publikováno v:
Oncology Reports. 49
Autor:
Agata Olejniczak-Kęder, Marta Bauer, Wojciech Kamysz, Emilia Sikorska, Damian Neubauer, Karol Sikora, Maciej Jaśkiewicz
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 7
International Journal of Molecular Sciences, Vol 22, Iss 3299, p 3299 (2021)
Volume 22
Issue 7
International Journal of Molecular Sciences, Vol 22, Iss 3299, p 3299 (2021)
Ultrashort cationic lipopeptides (USCLs) and gemini cationic surfactants are classes of potent antimicrobials. Our recent study has shown that the branching and shortening of the fatty acids chains with the simultaneous addition of a hydrophobic N-te
Autor:
Zbigniew Kmieć, Adrian Zubrzycki, Magdalena Szaryńska, Agata Olejniczak-Kęder, Anna Wardowska
Publikováno v:
Applied Sciences
Volume 11
Issue 21
Applied Sciences, Vol 11, Iss 10009, p 10009 (2021)
Volume 11
Issue 21
Applied Sciences, Vol 11, Iss 10009, p 10009 (2021)
Cancer cells, especially cancer stem cells (CSCs), are known for their therapeutic resistance and ability to induce a cancer relapse even many years after successful treatment. The quest for a novel protocol utilizing some commonly used non-oncologic
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej, Vol 70, Pp 1469-1482 (2016)
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, accounting for about 10% of total adult malignancies worldwide. The majority of CRC cases are diagnosed at the late stage; thus the investigation of the pathogenesis of early-stage
Publikováno v:
Novel Approaches in Cancer Study. 3
Autor:
Agata Olejniczak-Kęder, Zbigniew Kmieć, Agata Wronska, Magdalena Szaryńska, Kamila Siedlecka-Kroplewska
Publikováno v:
International Journal of Oncology.
The aim of this study was to examine the effects of 5‑fluorouracil (5‑FU), anti‑epidermal growth factor receptor (EGFR) antibody and aspirin (ASA) on the characteristics of two CRC cell lines, HCT116 and HT29, maintained in a spherical culture
Publikováno v:
Advanced materials (Deerfield Beach, Fla.). 31(28)
Autor:
Dariusz Łaski, Jarosław Kobiela, Agata Olejniczak, Zbigniew Kmieć, Magdalena Szaryńska, Zbigniew Śledziński
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-22 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-22 (2018)
The therapy of colorectal cancer (CRC) patients is often unsuccessful because of the presence of cancer stem cells (CSCs) resistant to conventional approaches. Dendritic cells (DC)-based protocols are believed to effectively supplement CRC therapy. O